Orphan designation: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol bedaquiline Treatment of tuberculosis, 26/08/2005 Withdrawn
Retrieved on:
Wednesday, April 3, 2024
Community, Civil service commission, Eurostat, Sneeze, Diagnosis, Granuloma, Cough, Prevalence, Cell, Disease, Infection, Tuberculosis, Central nervous system, Patient, Committee, Knowledge, Seriousness, Regulation, Bacteria, Meningitis, EMA, MDR TB, IRIS, Joint, Antimycobacterial, Periodic breathing, MDR, European, Fever, COMP, Safety, European Commission, Marketing, Lymphatic system, Pharmaceutical industry
Orphan designation: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol bedaquiline Treatment of tuberculosis, 26/08/2005 Withdrawn
Key Points:
Orphan designation: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol bedaquiline Treatment of tuberculosis, 26/08/2005 Withdrawn